|
ATXN7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.97299999963263E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.63469999999921E-05 |
| Normal-vs-Stage2 |
2.907900E-02 |
| Normal-vs-Stage3 |
9.05939999684691E-08 |
| Normal-vs-Stage4 |
1.64690000004075E-06 |
| Stage1-vs-Stage2 |
8.023400E-01 |
| Stage1-vs-Stage3 |
4.690000E-02 |
| Stage1-vs-Stage4 |
1.088780E-01 |
| Stage2-vs-Stage3 |
1.313440E-01 |
| Stage2-vs-Stage4 |
1.872980E-01 |
| Stage3-vs-Stage4 |
8.958800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.28429999968205E-07 |
| Normal-vs-AfricanAmerican |
1.65276999999353E-05 |
| Normal-vs-Asian |
4.188600E-01 |
| Caucasian-vs-AfricanAmerican |
2.568600E-01 |
| Caucasian-vs-Asian |
1.253990E-02 |
| AfricanAmerican-vs-Asian |
4.384000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.10969997027632E-09 |
| Normal-vs-Female |
2.218900E-03 |
| Male-vs-Female |
3.538800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.790000E-04 |
| Normal-vs-Age(41-60Yrs) |
1.205390E-04 |
| Normal-vs-Age(61-80Yrs) |
6.95640000047959E-08 |
| Normal-vs-Age(81-100Yrs) |
1.73150000004618E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.348400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.715400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.505400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.520300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.324300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.834250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.553400E-01 |
| Normal-vs-Grade 2 |
2.813600E-04 |
| Normal-vs-Grade 3 |
1.32659999652063E-08 |
| Normal-vs-Grade 4 |
1.64960000004211E-06 |
| Grade 1-vs-Grade 2 |
7.343900E-02 |
| Grade 1-vs-Grade 3 |
4.384200E-03 |
| Grade 1-vs-Grade 4 |
7.441200E-03 |
| Grade 2-vs-Grade 3 |
3.961500E-02 |
| Grade 2-vs-Grade 4 |
3.656200E-02 |
| Grade 3-vs-Grade 4 |
4.286600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.075200E-03 |
| Normal-vs-ccB subtype |
4.67069999998682E-06 |
| ccA subtype-vs-ccB subtype |
9.130400E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.48160000000586E-05 |
| Normal-vs-N1 |
3.795700E-02 |
| N0-vs-N1 |
4.366400E-01 |
|
|
